180 related articles for article (PubMed ID: 29415627)
1. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS).
Kant V; Vijayakumar S; Sahoo GC; Ali V; Singh K; Chaudhery SS; Das P
J Biomol Struct Dyn; 2019 Feb; 37(2):481-492. PubMed ID: 29415627
[TBL] [Abstract][Full Text] [Related]
2. The narrow active-site cleft of O-acetylserine sulfhydrylase from Leishmania donovani allows complex formation with serine acetyltransferases with a range of C-terminal sequences.
Raj I; Kumar S; Gourinath S
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):909-19. PubMed ID: 22868756
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of ligand recognition by OASS from E. histolytica: insights from structural and molecular dynamics simulation studies.
Raj I; Mazumder M; Gourinath S
Biochim Biophys Acta; 2013 Oct; 1830(10):4573-83. PubMed ID: 23747298
[TBL] [Abstract][Full Text] [Related]
4. Substrate-Induced Facilitated Dissociation of the Competitive Inhibitor from the Active Site of O-Acetyl Serine Sulfhydrylase Reveals a Competitive-Allostery Mechanism.
Singh AK; Ekka MK; Kaushik A; Pandya V; Singh RP; Banerjee S; Mittal M; Singh V; Kumaran S
Biochemistry; 2017 Sep; 56(37):5011-5025. PubMed ID: 28805060
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
[No Abstract] [Full Text] [Related]
6. Structural basis for interaction of O-acetylserine sulfhydrylase and serine acetyltransferase in the Arabidopsis cysteine synthase complex.
Francois JA; Kumaran S; Jez JM
Plant Cell; 2006 Dec; 18(12):3647-55. PubMed ID: 17194764
[TBL] [Abstract][Full Text] [Related]
7. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Design of Inhibitors of the Crucial Cysteine Biosynthetic Pathway Enzyme O-Acetyl Serine Sulfhydrylase.
Mazumder M; Gourinath S
Curr Top Med Chem; 2016; 16(9):948-59. PubMed ID: 26303427
[TBL] [Abstract][Full Text] [Related]
9. Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature.
Salsi E; Bayden AS; Spyrakis F; Amadasi A; Campanini B; Bettati S; Dodatko T; Cozzini P; Kellogg GE; Cook PF; Roderick SL; Mozzarelli A
J Med Chem; 2010 Jan; 53(1):345-56. PubMed ID: 19928859
[TBL] [Abstract][Full Text] [Related]
10. Validation of NAD synthase inhibitors for inhibiting the cell viability of
Mandal H; Vijayakumar S; Yadav S; Kumar Singh S; Das P
J Biomol Struct Dyn; 2019 Oct; 37(17):4481-4493. PubMed ID: 30526395
[TBL] [Abstract][Full Text] [Related]
11. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into the interaction of O-acetylserine sulfhydrylase with competitive, peptidic inhibitors by saturation transfer difference-NMR.
Benoni R; Pertinhez TA; Spyrakis F; Davalli S; Pellegrino S; Paredi G; Pezzotti A; Bettati S; Campanini B; Mozzarelli A
FEBS Lett; 2016 Apr; 590(7):943-53. PubMed ID: 27072053
[TBL] [Abstract][Full Text] [Related]
13. Fine tuning of the active site modulates specificity in the interaction of O-acetylserine sulfhydrylase isozymes with serine acetyltransferase.
Spyrakis F; Felici P; Bayden AS; Salsi E; Miggiano R; Kellogg GE; Cozzini P; Cook PF; Mozzarelli A; Campanini B
Biochim Biophys Acta; 2013 Jan; 1834(1):169-81. PubMed ID: 23000429
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of O-Acetylserine sulfhydralase (OASS) isoform 3 from Entamoeba histolytica: Pharmacophore-based virtual screening and validation of novel inhibitors.
Dharavath S; Vijayan R; Kumari K; Tomar P; Gourinath S
Eur J Med Chem; 2020 Apr; 192():112157. PubMed ID: 32145643
[TBL] [Abstract][Full Text] [Related]
15. The active site of O-acetylserine sulfhydrylase is the anchor point for bienzyme complex formation with serine acetyltransferase.
Huang B; Vetting MW; Roderick SL
J Bacteriol; 2005 May; 187(9):3201-5. PubMed ID: 15838047
[TBL] [Abstract][Full Text] [Related]
16. Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR.
Annunziato G; Pieroni M; Benoni R; Campanini B; Pertinhez TA; Pecchini C; Bruno A; Magalhães J; Bettati S; Franko N; Mozzarelli A; Costantino G
J Enzyme Inhib Med Chem; 2016; 31(sup4):78-87. PubMed ID: 27578398
[TBL] [Abstract][Full Text] [Related]
17. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
[TBL] [Abstract][Full Text] [Related]
18. In-silico studies on Myo inositol-1-phosphate synthase of
Sinha M; Jagadeesan R; Kumar N; Saha S; Kothandan G; Kumar D
J Biomol Struct Dyn; 2022 May; 40(8):3371-3384. PubMed ID: 33200690
[TBL] [Abstract][Full Text] [Related]
19. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
[TBL] [Abstract][Full Text] [Related]
20. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A
Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
